Nutor Jerry John, Gyamerah Akua O, Duah Henry Ofori, Asakitogum David Ayangba, Thompson Rachel G A, Alhassan Robert Kaba, Hamilton Alison
Department of Family Health Care Nursing, School of Nursing, University of California, San Francisco, San Francisco, California, United States of America.
Department of Community Health and Health Behavior, University of Buffalo, Buffalo, New York, United States of America.
PLOS Glob Public Health. 2024 Feb 29;4(2):e0002994. doi: 10.1371/journal.pgph.0002994. eCollection 2024.
Stigma and discrimination have been identified as significant barriers to HIV treatment among people living with HIV (PLWH). HIV stigma affects decision to seek HIV testing and early treatment. Evidence shows that HIV stigma undermines antiretroviral therapy (ART) adherence by affecting the psychological process such as adjusting and coping with social support. In Ghana, stigma toward PLWH occurs in many ways including rejection by their communities and family members, ostracism, and refusal to engage in social interactions such as eating, sharing a bed, or shaking hands. Therefore. we examined PLWH's experiences with different forms of HIV-related stigma and the impact on HIV treatment outcome in the Volta region of Ghana. We employed a convergent mixed-method approach consisting of a survey with 181 PLWH, four focus group discussions with 24 survey respondents, and in-depth interviews with six providers. We performed independent samples t-test, ANOVA, and chi-square test to test associations in bivariate analysis and analyzed qualitative data using thematic analysis. In all, 49% of survey respondents reported experiencing high internalized stigma, which was associated with high social support and depression (p<0.001). In qualitative interviews, anticipated stigma was the most salient concern of PLWH, followed by internalized and enacted stigma, which all negatively impacted HIV treatment and care. Stigma was experienced on multiple levels and affected psychosocial and treatment outcomes. Findings suggest urgent need for HIV-stigma reduction intervention among PLWH and their family, providers, and community members.
耻辱感和歧视已被确认为艾滋病毒感染者(PLWH)接受艾滋病毒治疗的重大障碍。艾滋病毒耻辱感影响寻求艾滋病毒检测和早期治疗的决定。有证据表明,艾滋病毒耻辱感通过影响诸如调整和应对社会支持等心理过程,破坏了抗逆转录病毒疗法(ART)的依从性。在加纳,对艾滋病毒感染者的耻辱感以多种方式表现出来,包括被其社区和家庭成员排斥、孤立,以及拒绝参与诸如一起吃饭、同床或握手等社交互动。因此,我们调查了加纳沃尔特地区艾滋病毒感染者在不同形式的与艾滋病毒相关耻辱感方面的经历及其对艾滋病毒治疗结果的影响。我们采用了一种聚合混合方法,包括对181名艾滋病毒感染者进行调查、与24名调查受访者进行四次焦点小组讨论,以及对六名医护人员进行深入访谈。我们进行了独立样本t检验、方差分析和卡方检验,以检验双变量分析中的关联,并使用主题分析来分析定性数据。总体而言,49%的调查受访者报告经历了高度的内化耻辱感,这与高社会支持和抑郁相关(p<0.001)。在定性访谈中,预期耻辱感是艾滋病毒感染者最突出的担忧,其次是内化耻辱感和表现出的耻辱感,所有这些都对艾滋病毒治疗和护理产生了负面影响。耻辱感在多个层面上都有体现,并影响了心理社会和治疗结果。研究结果表明,迫切需要对艾滋病毒感染者及其家人、医护人员和社区成员开展减少艾滋病毒耻辱感的干预措施。